Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,542,251
  • Shares Outstanding, K 33,411
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,990 K
  • 60-Month Beta -1.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.64
Trade SLNO with:

Options Overview Details

View History
  • Implied Volatility 57.46% ( -15.70%)
  • Historical Volatility 79.89%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 145.78% on 03/05/24
  • IV Low 57.46% on 05/17/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 335
  • Volume Avg (30-Day) 229
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 6,280
  • Open Int (30-Day) 5,885

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.63
  • Number of Estimates 3
  • High Estimate -0.59
  • Low Estimate -0.65
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.61 +26.09%
on 04/19/24
53.80 -14.20%
on 04/29/24
+8.26 (+21.79%)
since 04/17/24
3-Month
36.61 +26.09%
on 04/19/24
53.82 -14.23%
on 02/28/24
-1.16 (-2.45%)
since 02/16/24
52-Week
3.69 +1,150.95%
on 09/07/23
53.82 -14.23%
on 02/28/24
+41.86 (+973.49%)
since 05/17/23

Most Recent Stories

More News
Why Soleno Therapeutics Stock Is Skyrocketing Today

The clinical-stage biotech company received great news from the FDA.

SLNO : 46.16 (+1.10%)
Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up.

SLNO : 46.16 (+1.10%)
Why Shares of Soleno Therapeutics Dropped on Wednesday

Investors took profits a day after the clinical-stage biotech company's shares soared.

SLNO : 46.16 (+1.10%)
Shares of Soleno Therapeutics (NASDAQ: SLNO) Surge Over 500% After Its DCCR Candidate Shows Promise in PWS Clinical Trials

Breakthrough Results from Study C602 Soleno Therapeutics, Inc. (NASDAQ: SLNO), a trailblazer in the biopharmaceutical industry, recently unveiled its promising

SLNO : 46.16 (+1.10%)
Why Shares of Soleno Therapeutics Are Booming on Tuesday

Soleno announced positive top-line results for DCCR, its lead therapy.

SLNO : 46.16 (+1.10%)
Soleno Therapeutics, Inc. (SLNO) Upgraded to Strong Buy: What Does It Mean for the Stock?

Soleno Therapeutics, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SLNO : 46.16 (+1.10%)
Three Healthcare Penny Stocks to Watch In The New Year

These three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.

ACRX : 0.8600 (+7.50%)
HAPP : 4.50 (+1.35%)
SLNO : 46.16 (+1.10%)
Pre-Market Brief: Stocks Mostly Lower as Economic Outlook Darkens, BoJ Policy Shift

March S&P 500 futures (ESH23) are trending down -0.08% this morning after three major U.S. benchmark indices closed lower for a fourth straight session, with Nasdaq dropping the most as market participants'...

ESH23 : 3,957.05s (-0.09%)
META : 471.91 (-0.28%)
ICCM : 1.0400 (+1.96%)
LCID : 2.84 (-1.39%)
SLNO : 46.16 (+1.10%)
TERN : 5.90 (-3.91%)
SMCI : 887.89 (-1.83%)
Catalyst Pharmaceuticals (CPRX) Rallies 80.69% YTD: Here's Why

Catalyst (CPRX) price rallies on FDA approval of the sNDA of its lead drug, Firdapse, approved to treat LEMS in patients above six years of age.

CPRX : 16.49 (+0.55%)
AERI : 15.25 (+0.07%)
SLNO : 46.16 (+1.10%)
ACER : 0.6601 (-17.95%)
Catalyst Pharma's (CPRX) sNDA for Firdapse Approved by the FDA

Catalyst Pharmaceuticals (CPRX) announces FDA approval of its sNDA for Firdapse to include pediatric patients for treating Lambert-Eaton myasthenic syndrome.

CPRX : 16.49 (+0.55%)
AERI : 15.25 (+0.07%)
SLNO : 46.16 (+1.10%)
ACER : 0.6601 (-17.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 49.43
2nd Resistance Point 48.13
1st Resistance Point 47.14
Last Price 46.16
1st Support Level 44.85
2nd Support Level 43.55
3rd Support Level 42.56

See More

52-Week High 53.82
Last Price 46.16
Fibonacci 61.8% 34.67
Fibonacci 50% 28.75
Fibonacci 38.2% 22.84
52-Week Low 3.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar